Send PM
Followers 779
Posts 121136
Boards Moderated 18
Alias Born 09/05/2002

FREE
ABBV REPORT

Re: DewDiligence post# 664

Tuesday, 06/21/2022 2:10:13 PM

Tuesday, June 21, 2022 2:10:13 PM

Post# of 723
ABBV submits Qulipta sNDA for prevention of chronic migraine:

https://finance.yahoo.com/news/abbvie-submits-supplemental-drug-application-120000934.html

The FDA approved Qulipta for prevention of episodic migraine in Oct 2021 (#msg-166135709).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News